| Primary |
| Bronchopulmonary Aspergillosis |
27.3% |
| Aspergillosis |
12.1% |
| B-cell Lymphoma |
12.1% |
| Candidiasis |
9.1% |
| Fungal Infection |
9.1% |
| Drug Use For Unknown Indication |
6.1% |
| Ill-defined Disorder |
6.1% |
| Prophylaxis |
6.1% |
| Acute Myeloid Leukaemia |
3.0% |
| Bronchopulmonary Aspergillosis Allergic |
3.0% |
| Interstitial Lung Disease |
3.0% |
| Sinusitis Aspergillus |
3.0% |
|
| Hyperkalaemia |
8.0% |
| Liver Function Test Abnormal |
8.0% |
| Pyrexia |
8.0% |
| Renal Failure |
8.0% |
| Respiratory Failure |
8.0% |
| Death |
4.0% |
| Deep Vein Thrombosis |
4.0% |
| Drug Resistance |
4.0% |
| Facial Palsy |
4.0% |
| Gastrointestinal Haemorrhage |
4.0% |
| Haemoptysis |
4.0% |
| Hypoaesthesia |
4.0% |
| Nephropathy Toxic |
4.0% |
| Neurotoxicity |
4.0% |
| Pancreatitis |
4.0% |
| Photosensitivity Reaction |
4.0% |
| Polyneuropathy |
4.0% |
| Pseudoporphyria |
4.0% |
| Pulmonary Toxicity |
4.0% |
| Rash Erythematous |
4.0% |
|
| Secondary |
| Drug Use For Unknown Indication |
29.1% |
| Ill-defined Disorder |
7.9% |
| Sepsis |
7.9% |
| Aspergillosis |
7.3% |
| Fusarium Infection |
6.0% |
| Immunosuppression |
5.3% |
| Neoplasm |
4.6% |
| Bronchopulmonary Aspergillosis |
3.3% |
| Anti-infective Therapy |
2.6% |
| Graft Versus Host Disease |
2.6% |
| Graft Versus Host Disease In Skin |
2.6% |
| Infection Prophylaxis |
2.6% |
| Lung Infection |
2.6% |
| Prophylaxis |
2.6% |
| Renal Transplant |
2.6% |
| Acute Myeloid Leukaemia |
2.0% |
| Antifungal Prophylaxis |
2.0% |
| Hypertension |
2.0% |
| Pain |
2.0% |
| Respiratory Syncytial Virus Infection |
2.0% |
|
| Renal Failure Acute |
12.5% |
| Sepsis |
9.4% |
| Ventricular Fibrillation |
9.4% |
| Respiratory Syncytial Virus Infection |
6.3% |
| Rhinorrhoea |
6.3% |
| Venoocclusive Disease |
6.3% |
| Vitamin K Deficiency |
6.3% |
| Vomiting |
6.3% |
| Alanine Aminotransferase Increased |
3.1% |
| Drug Resistance |
3.1% |
| Gangrene |
3.1% |
| General Physical Health Deterioration |
3.1% |
| Hallucination |
3.1% |
| Hypotension |
3.1% |
| Liver Function Test Abnormal |
3.1% |
| Musculoskeletal Pain |
3.1% |
| Pathogen Resistance |
3.1% |
| Pneumonia |
3.1% |
| Pulmonary Congestion |
3.1% |
| Pyrexia |
3.1% |
|
| Concomitant |
| Multiple Myeloma |
26.8% |
| Acute Myeloid Leukaemia |
18.6% |
| Acute Lymphocytic Leukaemia |
10.7% |
| Bone Marrow Conditioning Regimen |
5.0% |
| Bone Marrow Transplant |
5.0% |
| Drug Use For Unknown Indication |
5.0% |
| Chronic Lymphocytic Leukaemia |
4.1% |
| Liver Transplant |
3.8% |
| Aspergillosis |
3.2% |
| B-cell Lymphoma |
2.2% |
| Lung Transplant |
2.2% |
| Stem Cell Transplant |
2.2% |
| Bronchopulmonary Aspergillosis |
1.6% |
| Myelodysplastic Syndrome |
1.6% |
| Non-small Cell Lung Cancer |
1.6% |
| Graft Versus Host Disease |
1.3% |
| Hodgkin's Disease |
1.3% |
| Ill-defined Disorder |
1.3% |
| Immunodeficiency Common Variable |
1.3% |
| Leukaemia |
1.3% |
|
| White Blood Cell Count Decreased |
20.6% |
| Thrombocytopenia |
12.7% |
| Pneumonia |
6.9% |
| Pyrexia |
5.9% |
| Vomiting |
5.9% |
| Respiratory Distress |
4.9% |
| Weight Increased |
4.9% |
| Wound Infection Staphylococcal |
3.9% |
| Pain |
2.9% |
| Renal Failure Acute |
2.9% |
| Renal Impairment |
2.9% |
| Respiratory Failure |
2.9% |
| Therapeutic Response Decreased |
2.9% |
| Thrombotic Thrombocytopenic Purpura |
2.9% |
| Transplant Rejection |
2.9% |
| Tumour Lysis Syndrome |
2.9% |
| Unresponsive To Stimuli |
2.9% |
| Varicose Vein |
2.9% |
| Venoocclusive Liver Disease |
2.9% |
| Death |
2.0% |
|
